What is TIRADS Level?

Most of the thyroid nodules discovered in individuals was identified via simple medical findings that birth from regular physical examinations or imaging studies.

Interestingly, majority of these thyroid nodules will not trouble you or your health but there are some few who may become problematic to you by becoming cancerous.

One major concern is individuals having so much unrest and fear any time nodule is discovered with them, because of the fear of it becoming cancerous.

This is the reason why the TIRADS (Thyroid Imaging Reporting and Data System) was developed to help nullify such fears by standardizing the assessment and reporting of thyroid nodules.

This system ensures accuracy in detecting thyroid malignancy, determining risk of malignancy by placing it in its category on the basis of the ultrasound features associated with malignancy.

This categorization system helps you as an individual to know the exact state of your thyroid condition and as well help your healthcare professionals to take the right approach in helping you manage your condition.

This article will give you adequate insights of the TIRADS levels as its being categorized through the characteristics they display via the use of ultrasound imaging.

Key Takeaway:

TIRADS (Thyroid Imaging Reporting and Data System): A classification system used to evaluate thyroid nodules based on ultrasound characteristics.

Purpose: Helps standardize the assessment of thyroid nodules and stratify the risk of malignancy.

Levels: Ranges from TIRADS 1 (benign) to TIRADS 5 (highly suspicious for malignancy).

Scoring: Each nodule is assigned points based on features like shape, margin, composition, and echogenicity.

Clinical Use: Guides decisions on whether a fine-needle aspiration (FNA) or further monitoring is needed.

Key Advantage: Improves consistency in diagnosis and reduces unnecessary biopsies.

For more information, check here and here.

The TIRADS (Thyroid Imaging Reporting and Data System) was introduced by the American College of Radiology (ACR) to help provide a structured approach for evaluating thyroid nodules using ultrasound imaging.

The system puts nodules into different levels on the basis of their peculiar ultrasound features that align with the risk of malignancy; these different levels are called TIRADS Level.

These different levels range from TR1 to TR5 and they include:

TR1 (Benign): The nodules in this category have the least risk of malignancy of less than one percent. They often appear as simple cysts or spongiform and will definitely not need any further testing.
TR2 (Not Suspicious): The nodules in this category also have a very low risk of malignancy of about two percent. They’ll usually not cause any threat and will definitely not need any further testing except in cases where some other clinical factors are present.
TR3 (Mildly Suspicious): The nodules in this category also have a low risk of malignancy of about five percent. They come with features like irregular margins or hypoechogenicity and will definitely need further testing using ultrasound monitoring or fine-needle aspiration (FNA) biopsy especially for larger nodules.
TR4 (Moderately Suspicious): The nodules in this category have a moderate risk of malignancy of between ten to twenty percent. They come with very suspicious features like microcalcifications and a taller-than-wide shape. Further testing like FNA biopsy is definitely needed to determine the nature of these nodules.
TR5 (Highly Suspicious): The nodules in this category have a very high risk of malignancy of more than thirty five percent. They show multiple suspicious characteristics and warrant FNA biopsy to confirm their diagnosis.

Related:

FAQs

What is TIRADS?

TIRADS stands for Thyroid Imaging Reporting and Data System. It is a classification system used to evaluate thyroid nodules based on ultrasound findings.

What do the TIRADS levels mean?

TIRADS levels range from TIRADS 1 to TIRADS 5. TIRADS 1 indicates a normal thyroid without nodules, while TIRADS 2 is for benign findings. TIRADS 3 represents a low risk of malignancy, TIRADS 4 indicates an intermediate risk, and TIRADS 5 suggests a high risk of cancer.

How is the TIRADS score determined?

The score is based on ultrasound features such as nodule composition, echogenicity, shape, margin, and calcifications. Points are assigned to these features, and the total determines the TIRADS level.

Why is TIRADS important?

TIRADS helps assess the risk of thyroid cancer and guides decisions on whether a biopsy or follow-up is needed. It also standardizes evaluations, improving accuracy and consistency.

Does a high TIRADS level mean I have cancer?

No, a high TIRADS level does not confirm cancer. It only indicates a higher risk, which may require further investigation like a biopsy.

What happens if my nodule is classified as TIRADS 4 or 5?

If a nodule is classified as TIRADS 4 or 5, your doctor may recommend a fine-needle aspiration (FNA) biopsy to determine if the nodule is malignant.

Can TIRADS levels change over time?

Yes, TIRADS levels can change. Nodules may grow, shrink, or develop new features over time, which can lead to reclassification during follow-up imaging.

Is TIRADS used worldwide?

Yes, TIRADS is a globally recognized system used by radiologists to standardize the evaluation of thyroid nodules.

Are there any risks in relying on TIRADS?

While TIRADS reduces unnecessary biopsies, it may occasionally miss some cancers or lead to biopsies of benign nodules. Regular follow-up is essential for accurate monitoring.

Who interprets TIRADS results?

A radiologist or trained healthcare provider interprets TIRADS results and works with your doctor to decide on the appropriate next steps.

Read also:

Conclusion

TIRADS plays a significant role in your thyroid health as an individual. It reduces unnecessarily biopsies especially on benign nodules, it ensures appropriate evaluation of malignant nodules and enhances prognosis and reducing complications.

Hence, regular monitoring and early intervention are vital for effectively managing your thyroid nodules and ensuring optimal health outcomes.

Reference

Dy JG, Kasala R, Yao C, Ongoco R, Mojica DJ. Thyroid Imaging Reporting and Data System (TIRADS) in Stratifying Risk of Thyroid Malignancy at The Medical City. J ASEAN Fed Endocr Soc. 2017;32(2):108-116. doi: 10.15605/jafes.032.02.03. Epub 2017 Aug 2. PMID: 33442093; PMCID: PMC7784109.
Sahli ZT, Karipineni F, Hang JF, Canner JK, Mathur A, Prescott JD, Sheth S, Ali SZ, Zeiger MA. The association between the ultrasonography TIRADS classification system and surgical pathology among indeterminate thyroid nodules. Surgery. 2019 Jan;165(1):69-74. doi: 10.1016/j.surg.2018.04.094. Epub 2018 Nov 8. PMID: 30415866; PMCID: PMC7103876.

0 Shares